1. Home
  2. JEF vs RDY Comparison

JEF vs RDY Comparison

Compare JEF & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JEF
  • RDY
  • Stock Information
  • Founded
  • JEF 1968
  • RDY 1984
  • Country
  • JEF United States
  • RDY India
  • Employees
  • JEF N/A
  • RDY N/A
  • Industry
  • JEF Investment Bankers/Brokers/Service
  • RDY Biotechnology: Pharmaceutical Preparations
  • Sector
  • JEF Finance
  • RDY Health Care
  • Exchange
  • JEF Nasdaq
  • RDY Nasdaq
  • Market Cap
  • JEF 11.8B
  • RDY 13.1B
  • IPO Year
  • JEF N/A
  • RDY N/A
  • Fundamental
  • Price
  • JEF $74.10
  • RDY $14.17
  • Analyst Decision
  • JEF Buy
  • RDY Buy
  • Analyst Count
  • JEF 3
  • RDY 1
  • Target Price
  • JEF $72.33
  • RDY $17.00
  • AVG Volume (30 Days)
  • JEF 1.6M
  • RDY 697.0K
  • Earning Date
  • JEF 01-06-2025
  • RDY 11-05-2024
  • Dividend Yield
  • JEF 1.89%
  • RDY 6.76%
  • EPS Growth
  • JEF 68.19
  • RDY 4.63
  • EPS
  • JEF 2.34
  • RDY 0.76
  • Revenue
  • JEF $6,250,606,000.00
  • RDY $3,579,112,656.00
  • Revenue This Year
  • JEF $46.58
  • RDY $13.39
  • Revenue Next Year
  • JEF $17.01
  • RDY $8.35
  • P/E Ratio
  • JEF $31.62
  • RDY $19.00
  • Revenue Growth
  • JEF 26.50
  • RDY 12.37
  • 52 Week Low
  • JEF $34.34
  • RDY $12.90
  • 52 Week High
  • JEF $75.81
  • RDY $16.89
  • Technical
  • Relative Strength Index (RSI)
  • JEF 72.29
  • RDY 30.39
  • Support Level
  • JEF $73.35
  • RDY $14.99
  • Resistance Level
  • JEF $75.41
  • RDY $15.19
  • Average True Range (ATR)
  • JEF 1.48
  • RDY 0.28
  • MACD
  • JEF 0.68
  • RDY -0.07
  • Stochastic Oscillator
  • JEF 85.63
  • RDY 11.43

About JEF Jefferies Financial Group Inc.

Jefferies Financial Group Inc is a diversified financial services company. It has two reportable segments; Investment Banking and Capital Markets which is also the majority revenue generating segment, includes securities, commodities, corporate lending, futures and foreign exchange capital markets activities and its investment banking business, which provides underwriting and financial advisory services to clients across different sectors. The Asset Management reportable business segment provides alternative investment management services to investors in the U.S. and overseas and generates investment income from capital invested in and managed by it or its affiliated asset managers.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: